Clinical Trial Update: Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating concurrent chemotherapy for recurrent T3/T4 nasopharyngeal carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING